Page 9 - CUA ESMO 2022

Abstracts To Be Discussed

• LBA9 - Duration of androgen deprivation therapy with post-

operative radiotherapy for prostate cancer: First results of the

RADICALS-HD trial

• LBA64 - Duration of androgen suppression with post-operative

radiotherapy (DADSPORT): A collaborative meta-analysis of

aggregate data

• LBA63 - PRESTO: A phase III, open-label study of androgen

annihilation in patients with high-risk biochemically relapsed

prostate cancer